MBNL2 Regulates DNA Damage Response via Stabilizing p21

被引:17
作者
Cai, Jin [1 ,2 ]
Wang, Ningchao [1 ,2 ]
Lin, Guanglan [1 ,2 ]
Zhang, Haowei [1 ,3 ]
Xie, Weidong [1 ,3 ]
Zhang, Yaou [1 ,3 ]
Xu, Naihan [1 ,3 ]
机构
[1] Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, State Key Lab Chem Oncogen, Shenzhen 518055, Peoples R China
[2] Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, Open FIESTA Ctr, Shenzhen 518055, Peoples R China
[3] Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, Inst Biopharmaceut & Hlth Engn, Shenzhen 518055, Peoples R China
基金
中国国家自然科学基金;
关键词
MBNL2; RNA-binding protein; p21; DNA damage response; Chk1; cancer;
D O I
10.3390/ijms22020783
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
RNA-binding proteins are frequently dysregulated in human cancer and able to modulate tumor cell proliferation as well as tumor metastasis through post-transcriptional regulation on target genes. Abnormal DNA damage response and repair mechanism are closely related to genome instability and cell transformation. Here, we explore the function of the RNA-binding protein muscleblind-like splicing regulator 2 (MBNL2) on tumor cell proliferation and DNA damage response. Transcriptome and gene expression analysis show that the PI3K/AKT pathway is enriched in MBNL2-depleted cells, and the expression of cyclin-dependent kinase inhibitor 1A (p21(CDKN1A)) is significantly affected after MBNL2 depletion. MBNL2 modulates the mRNA and protein levels of p21, which is independent of its canonical transcription factor p53. Moreover, depletion of MBNL2 increases the phosphorylation levels of checkpoint kinase 1 (Chk1) serine 345 (S345) and DNA damage response, and the effect of MBNL2 on DNA damage response is p21-dependent. MBNL2 would further alter tumor cell fate after DNA damage, MBNL2 knockdown inhibiting DNA damage repair and DNA damage-induced senescence, but promoting DNA damage-induced apoptosis.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 43 条
[1]   Senescence Evasion in Chemotherapy: A Sweet Spot for p21 [J].
Ashraf, Humza M. ;
Moser, Justin ;
Spencer, Sabrina L. .
CELL, 2019, 178 (02) :267-269
[2]   Control of cell cycle transcription during G1 and S phases [J].
Bertoli, Cosetta ;
Skotheim, Jan M. ;
de Bruin, Robertus A. M. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2013, 14 (08) :518-528
[3]   Cellular senescence: when bad things happen to good cells [J].
Campisi, Judith ;
di Fagagna, Fabrizio d'Adda .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (09) :729-740
[4]   Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response [J].
Cazzalini, Ornella ;
Scovassi, A. Ivana ;
Savio, Monica ;
Stivala, Lucia A. ;
Prosperi, Ennio .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2010, 704 (1-3) :12-20
[5]   A Novel Role for the RNA-Binding Protein FXR1P in Myoblasts Cell-Cycle Progression by Modulating p21/Cdkn1a/Cip1/Waf1 mRNA Stability [J].
Davidovic, Laetitia ;
Durand, Nelly ;
Khalfallah, Olfa ;
Tabet, Ricardo ;
Barbry, Pascal ;
Mari, Bernard ;
Sacconi, Sabrina ;
Moine, Herve ;
Bardoni, Barbara .
PLOS GENETICS, 2013, 9 (03)
[6]   A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO [J].
DIMRI, GP ;
LEE, XH ;
BASILE, G ;
ACOSTA, M ;
SCOTT, C ;
ROSKELLEY, C ;
MEDRANO, EE ;
LINSKENS, M ;
RUBELJ, I ;
PEREIRASMITH, O ;
PEACOCKE, M ;
CAMPISI, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9363-9367
[7]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[8]   Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts [J].
Fish, Lisa ;
Pencheva, Nora ;
Goodarzi, Hani ;
Tran, Hien ;
Yoshida, Mitsukuni ;
Tavazoie, Sohail F. .
GENES & DEVELOPMENT, 2016, 30 (04) :386-398
[9]   PI3K/Akt: getting it right matters [J].
Franke, T. F. .
ONCOGENE, 2008, 27 (50) :6473-6488
[10]   The 3′-untranslated region of p21WAF1 mRNA is a composite cis-acting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein [J].
Giles, KM ;
Daly, JM ;
Beveridge, DJ ;
Thomson, AM ;
Voon, DC ;
Furneaux, HM ;
Jazayeri, JA ;
Leedman, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :2937-2946